Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
This trial is a randomized, double-blind, two arms parallel groups, prospective intervention study.
Healthy, full term, newborn infants. [+4]
Infants concomitantly enrolled or scheduled to be enrolled in another trial. [+6]
This study will evaluate the safety and immune response of a single dose of a quadrivalent human papillomavirus (HPV) vaccine when given together with a tetanus-diphtheria (Td) vaccine in healthy children and adolescents aged 9 to 15 years. The study will compare participants who receive the HPV vaccine together with the Td vaccine with those who receive the HPV vaccine alone. The study will assess whether giving the two vaccines together produces an immune response to HPV that is not lower than giving the HPV vaccine alone.
Age 9-15 years; [+3]
Concurrent/other trial; [+4]
A Phase I, Double-Blind, Randomized, Placebo Controlled Trial to Evaluate Safety and Immunogenicity of Lipovaxin Tuberculosis Vaccine (Bio Farma) in Healthy Populations Aged 18-40 Years in Indonesia
Clinically Healthy participants aged 18-40 years; [+4]
Those who are currently diagnosed with tuberculosis or have a history of tubercu... [+9]
This is a phase 3, experimental, randomized, observer-blind, lot to lot consistency study. The primary objective of this study is to assess the protectivity of In-House Recombinant Hepatitis B vaccine 28 days after 3 doses immunization.
Healthy individual aged 10 - 50 years old, as determined by clinical judgment, i... [+2]
Subject concomitantly enrolled or scheduled to be enrolled in another trial. [+9]
Typhoid fever is a serious systemic infection caused by the enteric pathogen Salmonella enterica serovar typhi. S typhi is spread by the fecal-oral route. Although largely an endemic disease, S. typhi has epidemic potential. This research aims to determine the long-term immune response after administration of one dose of Bio TCV and PQed TCV vaccines in the population in Indonesia. Research participants will be taken from research participants who complete the Bio TCV (Typhoid 0319) Phase III clinical trial research included in the Main Study Group I.
Healthy [+2]
History of uncontrolled coagulopathy or blood disorders contraindicating for phl...
This trial is open label, comparative, randomized, phase I/II study, experimental, randomized, open-label, three arm parallel group study. The primary objective for phase I is to evaluate the safety of the DTwP-Hepatitis B-Hib-IPV (Bio Farma) vaccine within 7 days after each dose. The primary objective for phase II is to evaluate protectivity of DTwP-Hepatitis B-Hib-IPV (Bio Farma) vaccine.
Infant 6-11 weeks of age. [+4]
Child concomitantly enrolled or scheduled to be enrolled in another trial. [+8]
